{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T02:37:54Z","timestamp":1779331074410,"version":"3.51.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,9,29]],"date-time":"2009-09-29T00:00:00Z","timestamp":1254182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,9,29]],"date-time":"2009-09-29T00:00:00Z","timestamp":1254182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics J"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1038\/tpj.2009.45","type":"journal-article","created":{"date-parts":[[2009,9,29]],"date-time":"2009-09-29T10:26:57Z","timestamp":1254220017000},"page":"54-61","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":149,"title":["Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients"],"prefix":"10.1038","volume":"10","author":[{"given":"A V","family":"Khrunin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Moisseev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Gorbunova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Limborska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,9,29]]},"reference":[{"key":"BFtpj200945_CR1","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrc2167","volume":"7","author":"L Kelland","year":"2007","unstructured":"Kelland L . The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 2007; 7: 573\u2013584.","journal-title":"Nat Rev Cancer"},{"key":"BFtpj200945_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ctrv.2006.09.006","volume":"33","author":"CA Rabik","year":"2007","unstructured":"Rabik CA, Dolan ME . Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev 2007; 33: 9\u201323.","journal-title":"Cancer Treat Rev"},{"key":"BFtpj200945_CR3","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1056\/NEJMra020526","volume":"348","author":"WE Evans","year":"2003","unstructured":"Evans WE, McLeod HL . Pharmacogenomics\u2014drug disposition, drug targets, and side effects. N Engl J Med 2003; 348: 538\u2013548.","journal-title":"N Engl J Med"},{"key":"BFtpj200945_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10147-004-0467-4","volume":"10","author":"Y Yamayoshi","year":"2005","unstructured":"Yamayoshi Y, Iida E, Tanigawara Y . Cancer pharmacogenomics: international trends. Int J Clin Oncol 2005; 10: 5\u201313.","journal-title":"Int J Clin Oncol"},{"key":"BFtpj200945_CR5","first-page":"555","volume":"16","author":"JJ Yu","year":"2000","unstructured":"Yu JJ, Lee KB, Mu C, Li Q, Abernathy TV, Bostick-Bruton F et al. Comparison of two human ovarian carcinoma cell lines (A2780\/CP70 and MCAS) that are equally resistant to platinum, but differ at codon 118 of the ERCC1 gene. Int J Oncol 2000; 16: 555\u2013560.","journal-title":"Int J Oncol"},{"key":"BFtpj200945_CR6","first-page":"843","volume":"9","author":"P Chen","year":"2000","unstructured":"Chen P, Wiencke J, Aldape K, Kesler-Diaz A, Miike R, Kelsey K et al. Association of an ERCC1 polymorphism with adult-onset glioma. Cancer Epidemiol Biomarkers Prev 2000; 9: 843\u2013847.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFtpj200945_CR7","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1289\/ehp.6632","volume":"111","author":"WW Au","year":"2003","unstructured":"Au WW, Salama SA, Sierra-Torres SH . Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. Environ Health Perspect 2003; 111: 1843\u20131850.","journal-title":"Environ Health Perspect"},{"key":"BFtpj200945_CR8","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1097\/FPC.0b013e3280115e63","volume":"17","author":"KJ Wolfe","year":"2007","unstructured":"Wolfe KJ, Wickliffe JK, Hill CE, Paolini M, Ammenheuser MM, Abdel-Rahman SZ . Single nucleotide polymorphisms of the DNA repair gene XPD\/ERCC2 alter mRNA expression. Pharmacogenet Genomics 2007; 17: 897\u2013905.","journal-title":"Pharmacogenet Genomics"},{"key":"BFtpj200945_CR9","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1021\/cr068207j","volume":"107","author":"Y Jung","year":"2007","unstructured":"Jung Y, Lippard SJ . Direct cellular responses to platinum-induced DNA damage. Chem Rev 2007; 107: 1387\u20131407.","journal-title":"Chem Rev"},{"key":"BFtpj200945_CR10","first-page":"1663","volume":"10","author":"T Boulikas","year":"2003","unstructured":"Boulikas T, Vougiouka M . Cisplatin and platinum drugs at the molecular level. Oncol Rep 2003; 10: 1663\u20131682.","journal-title":"Oncol Rep"},{"key":"BFtpj200945_CR11","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/sj.onc.1209373","volume":"25","author":"CC McIlwain","year":"2006","unstructured":"McIlwain CC, Townsend DM, Tew KD . Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene 2006; 25: 1639\u20131648.","journal-title":"Oncogene"},{"key":"BFtpj200945_CR12","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/00008571-200210000-00006","volume":"12","author":"TM Ishimoto","year":"2002","unstructured":"Ishimoto TM, Ali-Osman F . Allelic variants of the human glutathione S-transferase P1 gene confer differential cytoprotection against anticancer agents in Escherichia coli. Pharmacogenetics 2002; 12: 543\u2013553.","journal-title":"Pharmacogenetics"},{"key":"BFtpj200945_CR13","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1158\/1535-7163.MCT-08-0250","volume":"7","author":"C Peklak-Scott","year":"2008","unstructured":"Peklak-Scott C, Smitherman PK, Townsend AJ, Morrow CS . Role of glutathione S-transferase P1-1 in the cellular detoxification of cisplatin. Mol Cancer Ther 2008; 7: 3247\u20133255.","journal-title":"Mol Cancer Ther"},{"key":"BFtpj200945_CR14","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/jnci\/94.12.936","volume":"94","author":"J Stoehlmacher","year":"2002","unstructured":"Stoehlmacher J, Park DJ, Zhang W, Groshen S, Tsao-Wei DD, Yu MC et al. Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer. J Natl Cancer Inst 2002; 94: 936\u2013942.","journal-title":"J Natl Cancer Inst"},{"key":"BFtpj200945_CR15","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1136\/ijgc-00009577-200403000-00010","volume":"14","author":"RE Howells","year":"2004","unstructured":"Howells RE, Dhar KK, Hoban PR, Jones PW, Fryer AA, Redman CW et al. Association between glutathione-S-transferase GSTP1 genotypes, GSTP1 over-expression, and outcome in epithelial ovarian cancer. Int J Gynecol Cancer 2004; 14: 242\u2013250.","journal-title":"Int J Gynecol Cancer"},{"key":"BFtpj200945_CR16","doi-asserted-by":"publisher","first-page":"4749","DOI":"10.1158\/1078-0432.CCR-04-2333","volume":"11","author":"JM Lee","year":"2005","unstructured":"Lee JM, Wu MT, Lee YC, Yang SY, Chen JS, Hsu HH et al. Association of GSTP1 polymorphism and survival for esophageal cancer. Clin Cancer Res 2005; 11: 4749\u20134753.","journal-title":"Clin Cancer Res"},{"key":"BFtpj200945_CR17","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ygyno.2005.08.035","volume":"100","author":"A Beeghly","year":"2006","unstructured":"Beeghly A, Katsaros D, Chen H, Fracchioli S, Zhang Y, Massobrio M et al. Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival. Gynecol Oncol 2006; 100: 330\u2013337.","journal-title":"Gynecol Oncol"},{"key":"BFtpj200945_CR18","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.bbrc.2005.11.176","volume":"340","author":"AM Santos","year":"2006","unstructured":"Santos AM, Sousa H, Portela C, Pereira D, Pinto D, Catarino R et al. TP53 and P21 polymorphisms: response to cisplatinum\/paclitaxel-based chemotherapy in ovarian cancer. Biochem Biophys Res Commun 2006; 340: 256\u2013262.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFtpj200945_CR19","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ejca.2006.09.011","volume":"43","author":"CM Nagle","year":"2007","unstructured":"Nagle CM, Chenevix-Trench G, Spurdle AB, Webb PM . The role of glutathione-S-transferase polymorphisms in ovarian cancer survival. Eur J Cancer 2007; 43: 283\u2013290.","journal-title":"Eur J Cancer"},{"key":"BFtpj200945_CR20","doi-asserted-by":"publisher","first-page":"S223","DOI":"10.1016\/j.ygyno.2007.07.024","volume":"107","author":"JS Saldivar","year":"2007","unstructured":"Saldivar JS, Lu KH, Liang D, Gu J, Huang M, Vlastos AT et al. Moving toward individualized therapy based on NER polymorphisms that predict platinum sensitivity in ovarian cancer patients. Gynecol Oncol 2007; 107: S223\u2013S229.","journal-title":"Gynecol Oncol"},{"key":"BFtpj200945_CR21","doi-asserted-by":"publisher","first-page":"5172","DOI":"10.1200\/JCO.2007.11.8547","volume":"25","author":"S Smith","year":"2007","unstructured":"Smith S, Su D, Rigault de la Longrais IA, Schwartz P, Puopolo M, Rutherford TJ et al. ERCC1 genotype and phenotype in epithelial ovarian cancer identify patients likely to benefit from paclitaxel treatment in addition to platinum-based therapy. J Clin Oncol 2007; 25: 5172\u20135179.","journal-title":"J Clin Oncol"},{"key":"BFtpj200945_CR22","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1200\/JCO.2006.08.1844","volume":"25","author":"A Ruzzo","year":"2007","unstructured":"Ruzzo A, Graziano F, Loupakis F, Rulli E, Canestrari E, Santini D et al. Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFOX-4 chemotherapy. J Clin Oncol 2007; 25: 1247\u20131254.","journal-title":"J Clin Oncol"},{"key":"BFtpj200945_CR23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/oso\/9780199636341.003.0002","volume-title":"Molecular Genetic Analysis of Populations","author":"BG Milligan","year":"1998","unstructured":"Milligan BG . Total DNA isolation. In: Hoelzel AR (ed). Molecular Genetic Analysis of Populations. Oxford University Press: London, 1998. pp 29\u201360."},{"key":"BFtpj200945_CR24","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1097\/00008571-200111000-00004","volume":"11","author":"BF Coles","year":"2001","unstructured":"Coles BF, Morel F, Rauch C, Huber WW, Yang M, Teitel CH et al. Effect of polymorphism in the human glutathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression. Pharmacogenetics 2001; 11: 663\u2013669.","journal-title":"Pharmacogenetics"},{"key":"BFtpj200945_CR25","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/00008571-200406000-00005","volume":"14","author":"N Tetlow","year":"2004","unstructured":"Tetlow N, Robinson A, Mantle T, Board P . Polymorphism of human mu class glutathione transferases. Pharmacogenetics 2004; 14: 359\u2013368.","journal-title":"Pharmacogenetics"},{"key":"BFtpj200945_CR26","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1136\/thx.54.8.693","volume":"54","author":"T Ishii","year":"1999","unstructured":"Ishii T, Matsuse T, Teramoto S, Matsui H, Miyao M, Hosoi T et al. Glutathione S-transferase P1 (GSTP1) polymorphism in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: 693\u2013696.","journal-title":"Thorax"},{"key":"BFtpj200945_CR27","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/(SICI)1097-0215(19980812)77:4<516::AID-IJC7>3.0.CO;2-X","volume":"77","author":"ST Saarikoski","year":"1998","unstructured":"Saarikoski ST, Voho A, Reinikainen M, Anttila S, Karjalainen A, Malaveille C et al. Combined effect of polymorphic gst genes on individual susceptibility to lung cancer. Int J Cancer 1998; 77: 516\u2013521.","journal-title":"Int J Cancer"},{"key":"BFtpj200945_CR28","doi-asserted-by":"publisher","first-page":"4939","DOI":"10.1158\/1078-0432.CCR-04-0247","volume":"10","author":"W Zhou","year":"2004","unstructured":"Zhou W, Gurubhagavatula S, Liu G, Park S, Neuberg DS, Wain JC et al. Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. Clin Cancer Res 2004; 10: 4939\u20134943.","journal-title":"Clin Cancer Res"},{"key":"BFtpj200945_CR29","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/carcin\/22.9.1437","volume":"22","author":"G Matullo","year":"2001","unstructured":"Matullo G, Palli D, Peluso M, Guarrera S, Carturan S, Celentano E et al. XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. Carcinogenesis 2001; 22: 1437\u20131445.","journal-title":"Carcinogenesis"},{"key":"BFtpj200945_CR30","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1093\/carcin\/23.6.1003","volume":"23","author":"J Tuimala","year":"2002","unstructured":"Tuimala J, Szekely G, Gundy S, Hirvonen A, Norppa H . Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: role in mutagen sensitivity. Carcinogenesis 2002; 23: 1003\u20131008.","journal-title":"Carcinogenesis"},{"key":"BFtpj200945_CR31","doi-asserted-by":"publisher","first-page":"3761","DOI":"10.1182\/blood-2002-04-1152","volume":"100","author":"C Seedhouse","year":"2002","unstructured":"Seedhouse C, Bainton R, Lewis M, Harding A, Russell N, Das-Gupta E . The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia. Blood 2002; 100: 3761\u20133766.","journal-title":"Blood"},{"key":"BFtpj200945_CR32","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1159\/000154275","volume":"45","author":"A Sjalander","year":"1995","unstructured":"Sjalander A, Birgander R, Kivela A, Beckman G . p53 polymorphisms and haplotypes in different ethnic groups. Hum Hered 1995; 45: 144\u2013149.","journal-title":"Hum Hered"},{"key":"BFtpj200945_CR33","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1136\/mp.53.2.88","volume":"53","author":"NA Wong","year":"2000","unstructured":"Wong NA, Rae F, Simpson KJ, Murray GD, Harrison DJ . Genetic polymorphisms of cytochrome p4502E1 and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a white population: a study and literature review, including meta-analysis. Mol Pathol 2000; 53: 88\u201393.","journal-title":"Mol Pathol"},{"key":"BFtpj200945_CR34","first-page":"1","volume":"432","author":"E Fritsche","year":"2000","unstructured":"Fritsche E, Pittman GS, Bell DA . Localization, sequence analysis, and ethnic distribution of a 96-bp insertion in the promoter of the human CYP2E1 gene. Mutat Res 2000; 432: 1\u20135.","journal-title":"Mutat Res"},{"key":"BFtpj200945_CR35","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1093\/carcin\/22.7.1053","volume":"22","author":"A Loktionov","year":"2001","unstructured":"Loktionov A, Watson MA, Gunter M, Stebbings WS, Speakman CT, Bingham SA . Glutathione-S-transferase gene polymorphisms in colorectal cancer patients: interaction between GSTM1 and GSTM3 allele variants as a risk-modulating factor. Carcinogenesis 2001; 22: 1053\u20131060.","journal-title":"Carcinogenesis"},{"key":"BFtpj200945_CR36","first-page":"1429","volume":"44","author":"AV Khrunin","year":"2008","unstructured":"Khrunin AV, Khokhrin DV, Limborska SA . Glutathione-S-transferase gene polymorphism in Russian populations of European part of Russia. Genetika 2008; 44: 1429\u20131434.","journal-title":"Genetika"},{"key":"BFtpj200945_CR37","doi-asserted-by":"publisher","first-page":"4528","DOI":"10.1200\/JCO.2006.10.4752","volume":"25","author":"S Marsh","year":"2007","unstructured":"Marsh S, Paul J, King CR, Gifford G, McLeod HL, Brown R . Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: the Scottish Randomised Trial in Ovarian Cancer. J Clin Oncol 2007; 25: 4528\u20134535.","journal-title":"J Clin Oncol"},{"key":"BFtpj200945_CR38","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00280-005-0041-4","volume":"57","author":"J Goodisman","year":"2006","unstructured":"Goodisman J, Hagrman D, Tacka KA, Souid AK . Analysis of cytotoxicities of platinum compounds. Cancer Chemother Pharmacol 2006; 57: 257\u2013267.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BFtpj200945_CR39","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1093\/toxsci\/kfj037","volume":"89","author":"J Ping","year":"2006","unstructured":"Ping J, Wang H, Huang M, Liu ZS . Genetic analysis of glutathione S-transferase A1 polymorphism in the Chinese population and the influence of genotype on enzymatic properties. Toxicol Sci 2006; 89: 438\u2013443.","journal-title":"Toxicol Sci"},{"key":"BFtpj200945_CR40","first-page":"6215","volume":"54","author":"HA Dirven","year":"1994","unstructured":"Dirven HA, van Ommen B, van Bladeren PJ . Involvement of human glutathione S-transferase isoenzymes in the conjugation of cyclophosphamide metabolites with glutathione. Cancer Res 1994; 54: 6215\u20136220.","journal-title":"Cancer Res"},{"key":"BFtpj200945_CR41","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1021\/tx950143c","volume":"9","author":"HA Dirven","year":"1996","unstructured":"Dirven HA, van Ommen B, van Bladeren PJ . Glutathione conjugation of alkylating cytostatic drugs with a nitrogen mustard group and the role of glutathione S-transferases. Chem Res Toxicol 1996; 9: 351\u2013360.","journal-title":"Chem Res Toxicol"},{"key":"BFtpj200945_CR42","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/ijc.10896","volume":"103","author":"C Sweeney","year":"2003","unstructured":"Sweeney C, Ambrosone CB, Joseph L, Stone A, Hutchins LF, Kadlubar FF et al. Association between a glutathione S-transferase A1 promoter polymorphism and survival after breast cancer treatment. Int J Cancer 2003; 103: 810\u2013814.","journal-title":"Int J Cancer"},{"key":"BFtpj200945_CR43","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1158\/1078-0432.CCR-05-2076","volume":"12","author":"T Lecomte","year":"2006","unstructured":"Lecomte T, Landi B, Beaune P, Laurent-Puig P, Loriot MA . Glutathione S-transferase P1 polymorphism (Ile105Val) predicts cumulative neuropathy in patients receiving oxaliplatin-based chemotherapy. Clin Cancer Res 2006; 12: 3050\u20133056.","journal-title":"Clin Cancer Res"},{"key":"BFtpj200945_CR44","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1200\/JCO.2006.08.9599","volume":"25","author":"J Oldenburg","year":"2007","unstructured":"Oldenburg J, Kraggerud SM, Cvancarova M, Lothe RA, Fossa SD . Cisplatin-induced long-term hearing impairment is associated with specific glutathione S-transferase genotypes in testicular cancer survivors. J Clin Oncol 2007; 25: 708\u2013714.","journal-title":"J Clin Oncol"},{"key":"BFtpj200945_CR45","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1097\/00001813-200009000-00007","volume":"11","author":"U Peters","year":"2000","unstructured":"Peters U, Preisler-Adams S, Hebeisen A, Hahn M, Seifert E, Lanvers C et al. Glutathione S-transferase genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin. Anticancer Drugs 2000; 11: 639\u2013643.","journal-title":"Anticancer Drugs"},{"key":"BFtpj200945_CR46","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1358\/dot.2003.39.10.799471","volume":"39","author":"R Rosell","year":"2003","unstructured":"Rosell R, Taron M, Camps C, L\u00f3pez-Vivanco G . Influence of genetic markers on survival in non-small cell lung cancer. Drugs Today (Barc) 2003; 39: 775\u2013786.","journal-title":"Drugs Today (Barc)"},{"key":"BFtpj200945_CR47","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/BF03256260","volume":"11","author":"L Gossage","year":"2007","unstructured":"Gossage L, Madhusudan S . Cancer pharmacogenomics: role of DNA repair genetic polymorphisms in individualizing cancer therapy. Mol Diagn Ther 2007; 11: 361\u2013380.","journal-title":"Mol Diagn Ther"},{"key":"BFtpj200945_CR48","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/jnci\/94.9.681","volume":"94","author":"X Wu","year":"2002","unstructured":"Wu X, Zhao H, Amos CI, Shete S, Makan N, Hong WK et al. p53 genotypes and haplotypes associated with lung cancer susceptibility and ethnicity. J Natl Cancer Inst 2002; 94: 681\u2013690.","journal-title":"J Natl Cancer Inst"},{"key":"BFtpj200945_CR49","doi-asserted-by":"publisher","first-page":"158","DOI":"10.4161\/cc.7.2.5249","volume":"7","author":"SE Bojesen","year":"2008","unstructured":"Bojesen SE, Nordestgaard BG . The common germline Arg72Pro polymorphism of p53 and increased longevity in humans. Cell Cycle 2008; 7: 158\u2013163.","journal-title":"Cell Cycle"},{"key":"BFtpj200945_CR50","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00432-006-0099-3","volume":"132","author":"EC Morari","year":"2006","unstructured":"Morari EC, Lima AB, Bufalo NE, Leite JL, Granja F, Ward LS . Role of glutathione-S-transferase and codon 72 of P53 genotypes in epithelial ovarian cancer patients. J Cancer Res Clin Oncol 2006; 132: 521\u2013528.","journal-title":"J Cancer Res Clin Oncol"},{"key":"BFtpj200945_CR51","first-page":"687","volume":"26","author":"A Gadducci","year":"2006","unstructured":"Gadducci A, Di Cristofano C, Zavaglia M, Giusti L, Menicagli M, Cosio S et al. P53 gene status in patients with advanced serous epithelial ovarian cancer in relation to response to paclitaxel-plus platinum-based chemotherapy and long-term clinical outcome. Anticancer Res 2006; 26: 687\u2013693.","journal-title":"Anticancer Res"},{"key":"BFtpj200945_CR52","first-page":"863","volume":"22","author":"H Liu","year":"2002","unstructured":"Liu H, Baliga M, Baliga R . Effect of cytochrome P450 2E1 inhibitors on cisplatin-induced cytotoxicity to renal proximal tubular epithelial cells. Anticancer Res 2002; 22: 863\u2013868.","journal-title":"Anticancer Res"},{"key":"BFtpj200945_CR53","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1046\/j.1523-1755.2003.00908.x","volume":"63","author":"H Liu","year":"2003","unstructured":"Liu H, Baliga R . Cytochrome P450 2E1 null mice provide novel protection against cisplatin-induced nephrotoxicity and apoptosis. Kidney Int 2003; 63: 1687\u20131696.","journal-title":"Kidney Int"}],"container-title":["The Pharmacogenomics Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/tpj200945.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tpj200945","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tpj200945.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T20:41:33Z","timestamp":1710621693000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tpj200945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,29]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["BFtpj200945"],"URL":"https:\/\/doi.org\/10.1038\/tpj.2009.45","relation":{},"ISSN":["1470-269X","1473-1150"],"issn-type":[{"value":"1470-269X","type":"print"},{"value":"1473-1150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,29]]},"assertion":[{"value":"21 April 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}